ALFA Finder| Order book | Strong order book mentioned for NSE listing period. |
|---|---|
| Demand visibility | Expanding through population-scale screening initiatives. |
| Management confidence | High |
Growth
No specific revenue or profit growth figures for Q1 FY27 are provided in the presentation.
Outlook
Focus on Made-in-India MRI production (2025), scaling AI screening pathways (MIDAS), and global expansion in MENA and SEA.
Risks
Market fluctuations, regulatory changes, technology cycles, and reliance on partner clinical validations.
Last quarter's promises, checked
Delivered
- Revenue split 70% India/30% export in H1 FY26 → Delivered 120% YoY growth with 30% export share (= BEAT)
- H1 FY26 PAT growth improvement → Delivered 107x YoY increase to INR 38 crores (= BEAT)
- Domestic MRI manufacturing launch → First accredited Make-in-India MRI system established (= BEAT)
Partly delivered
- Nanomedic CDSCO approval by end of Nov 2025 → Pending approval, awaiting final certification for MD 26/27 (= PARTIAL)
Investor Presentation filed with NSE, NSE: FISCHER. Summary written with AI assistance from the document.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹25.13
- Market cap
- ₹1,741 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 58.4×Sector 35.5×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Board Meeting Date
Fischer Medical Ventures has intimated a board meeting on 14 November 2026 to consider unaudited Q2 results. The trading window stays closed until 48 hours after results.
Fischer Medical Ventures Management Change
Fischer Medical Ventures appointed Mr. Chan Sing En as Independent Director of SG subsidiary FMV Global Innovations, effective 27 Oct 2026. No financial consideration involved.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.